Advanced Process Control (APC) describes a set of tools used in process industries that are far more sophisticated than basic control strategies, such as PID control. Model Predictive Control (MPC) is a well-proven APC technique widely used in many process industries that is now delivering significant benefits within the pharmaceutical sector. This has a proven track record of delivering improved product quality, higher yield, greater agility and tangible savings in time, cost and energy.
In 'standard' pharmaceutical control, variability from raw materials - and the process itself - is passed directly through to the product, affecting yield, throughput and final quality. APC does not replace this 'standard' pharmaceutical control; rather, it is the next evolutionary step, combining process responses with offline and online quality measurement, to deliver true optimisation.
Furthermore, APC enables and supports new technologies such as continuous manufacturing, real-time release, micro-factories and customized medicines.
MPC simultaneously controls and optimises process operation in real-time:
Model
A dynamic multi-variable model is built that describes the relationships between Critical Process Parameters (CPP) and Critical Quality Attributes (CQAs). PharmaMV supports Pharma 4.0 techniques such as the use of mechanistic Digital Twins, Machine Learning and automated modelling to streamline model development and maintenance
Predictive
The model is used to predict future behaviour of the process including the impact of known disturbances such as raw material variability (CMAs). The controller continuously monitors the model performance in real-time.
Control
At regular intervals, the controller calculates an optimal set of coordinated adjustments to multiple CPPs in order to control the process Critical Quality Parameters. It exploits all opportunities to maximise product quality and process robustness. It stabilises the production process by compensating for disturbances using the model’s predictions and feedback.
Throughout development to manufacturing, data is key to enable rapid response to market demand. The knowledge to enable intelligent decisions and the wisdom to optimise the complete product lifecycle is now at your fingertips. The latest release of PerceptiveAPC v8.0 delivers the next
PD2M May 18-20 2021 Virtual This is the place to explore what pharmaceutical manufacturing will look like in 2030, sharing discussions on new ways to develop medicines. How will Industry 4.0 enable us to respond to market demand, delivering flexible, modular manufacturing and bringing
18-19 May 2021 Virtual Perceptive Engineering - an Applied Materials company - is looking forward to participating in the Bionow Pharma Manufacturing Conference 2021. We will be joining AstraZeneca and Bristol Meyers Squibb in session 2, discussing the ‘Digitisation of Pharma
© Perceptive Engineering Ltd 2022